ArielRamiezPorcallaMD

PubMed

• 1 citations
  A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity.
  Negar Alami, David C Carter, Nisha V Kwatra, Weihan Zhao, Linda Snodgrass, Ariel R Porcalla, Cheri E Klein, Daniel E Cohen, Loretta Gallenberg, Melina Neenan, Robert A...> ;Plos Neglected Tropical Diseases. 2023 Jul 1
• 8 citations
  Extrapolation as a Default Strategy in Pediatric Drug Development.
  Margaret Gamalo, Christina Bucci-Rechtweg, Robert M Nelson, Linh Vanh, Ariel Porcalla, Helen Thackray, Freda Cooner, Lauren Cutler, Danielle Friend, Ron Portman> ;Therapeutic Innovation & Regulatory Science. 2022 Nov 1
• 50 citations
  Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis
  Pietro Lampertico, José A. Carrión, Michael P. Curry, Juan Turnes, Markus Cornberg, Francesco Negro, Ashley Brown, Marcello Persico, Nicole Wick, Ariel Porcalla, Andre...> ;Journal of Hepatology. 2020 Jun 1
• 39 citations
  Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection
  Eric Lawitz, Robert Flisiak, Manal Abunimeh, Meghan E. Sise, Jun Yong Park, Marwan Kaskas, Annette Bruchfeld, Marcus-Alexander Wörns, Andrea Aglitti, Philippe J. Zamor...> ;Liver International. 2020 May 1
• 54 citations
  Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study
  Maureen M. Jonas, Robert H. Squires, Susan M. Rhee, Chih‐Wei Lin, Kazuhiko Bessho, Cornelia Feiterna-Sperling, Loreto Hierro, Deirdre Kelly, Simon C. Ling, Tatiana Str...> ;Hepatology. 2020 Feb 1
• 26 citations
  Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease
  Edward Gane, Fred Poordad, Neddie Zadeikis, Joaquin Mario Valdes, C.-W. Lin, Wei Liu, Armen Asatryan, Stanley Wang, Catherine A.M. Stedman, S. Greenbloom, T. Nguyen, M...> ;Clinical Infectious Diseases. 2019 Oct 30
• 7 citations
  Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study.
  Robert J. Fontana, Sabela Lens, Stuart McPherson, Magdy Elkhashab, Victor Ankoma-Sey, Mark Bondin, Ana Gabriela Pires dos Santos, Zhenyi Xue, Roger Trinh, Ariel Porcal...> ;Advances in Therapy. 2019 Oct 23
• 42 citations
  Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase...
  Tarik Asselah, Samuel S. Lee, Betty B. Yao, T. Nguyen, Florence Wong, Adam Mahomed, Seng Gee Lim, Armand Abergel, Joe Sasadeusz, Edward Gane, Neddie Zadeikis, Gretja S...> ;The Lancet. Gastroenterology & Hepatology. 2019 Jan 1
• 128 citations
  Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
  Nancy Reau, Paul Y. Kwo, Susan Rhee, Robert S. Brown, Kosh Agarwal, Peter W Angus, Edward Gane, Jia-Horng Kao, Parvez S. Mantry, David Mutimer, K. Rajender Reddy, Tram...> ;Hepatology. 2018 Jul 25
• 1 citations
  An Innovative, Collaborative, and Strategic Approach to Proactively Evaluate and Update Drug Interactions Based on Prescribing Information of Newly Approved Medicinal ...
  Ariel Porcalla, Nella Barshteyn, Scott Snyder, Mondira Bhattacharya> ;Therapeutic Innovation & Regulatory Science. 2017 May 11
• 50 citations
  Towards early inclusion of children in tuberculosis drugs trials : a consensus statement
  Sharon Nachman, Amina Ahmed, Farhana Amanullah, Mercedes C. Becerra, Radu Botgros, Grania Brigden, Renee Browning, Elizabeth Gardiner, Richard Hafner, Anneke C. Hessel...> ;The Lancet. Infectious Diseases. 2015 Jun 1
• 16 citations
  Soft tissue and cartilage infection by Salmonella oranienburg in a healthy girl.
  Ariel R. Porcalla, William J. Rodriguez> ;Southern Medical Journal. 2001 Apr 1
• The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?
  Porcalla, A. R., Sable, C. A., Patel, K. M., Martin, G. R., Singh, N.> ;Pediatr Cardiol. 2005 Nov 01
• Join now to see all